aTyr Pharma (471) Stock Forecast & Price Target
471 Analyst Ratings
471 Stock 12 Month Forecast
Average Price Target
EUR 0.89▲(284.85% Upside)Detailed List of Analyst Forecasts
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Joseph Pantginis | H.C. Wainwright | ― | hold | ― | Reiterated | 09/24/26 | ||
| Boris Peaker | JonesTrading | ― | hold | ― | Reiterated | 08/10/26 | ||
| Derek Archila | Wells Fargo | EUR 35.70 | hold | 15286.27%Upside | Assigned | 08/10/26 | ||
| Brian Abrahams | RBC Capital | EUR 35.70 | hold | 15286.27%Upside | Reiterated | 08/09/26 | ||
| Yasmeen Rahimi | Piper Sandler | EUR 249.87 | buy | 107603.90%Upside | Reiterated | 07/16/26 | ||
| Ilya Zubkov | Freedom Capital Markets | EUR 35.70→EUR 124.94 | buy | 53751.95%Upside | Upgraded | 05/20/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Joseph Pantginis | 09/24/26 | ― | hold | ― | Reiterated | H.C. Wainwright | ||
| Boris Peaker | 08/10/26 | ― | hold | ― | Reiterated | JonesTrading | ||
| Derek Archila | 08/10/26 | EUR 35.70 | hold | 15286.27%Upside | Assigned | Wells Fargo | ||
| Brian Abrahams | 08/09/26 | EUR 35.70 | hold | 15286.27%Upside | Reiterated | RBC Capital | ||
| Yasmeen Rahimi | 07/16/26 | EUR 249.87 | buy | 107603.90%Upside | Reiterated | Piper Sandler | ||
| Ilya Zubkov | 05/20/26 | EUR 35.70→EUR 124.94 | buy | 53751.95%Upside | Upgraded | Freedom Capital Markets |
Best Analysts Covering aTyr Pharma
Copying Yasmeen Rahimi's trades and holding each position for 3 Months would result in ― of your transactions generating a profit, with an average return of ― per trade.
Copying Yasmeen Rahimi's trades and holding each position for 1 Year would result in ― of your transactions generating a profit, with an average return of ― per trade.
Copying Yasmeen Rahimi's trades and holding each position for 2 Years would result in ― of your transactions generating a profit, with an average return of ― per trade.
471 Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 2 | 4 | 2 | 2 | 0 |
| Hold | 7 | 9 | 8 | 8 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 9 | 13 | 10 | 10 | 5 |
In the current month, 471 has received 0 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. 471 average Analyst price target in the past 3 months is 0.89.
471 Financial Forecast
471 Earnings Forecast
Next quarter’s earnings estimate for 471 is -EUR 3.57 with a range of -EUR 4.28 to -EUR 2.86. The previous quarter’s EPS was ―. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
471 Sales Forecast
Next quarter’s sales forecast for 471 is EUR 0 with a range of EUR 0 to EUR 0. The previous quarter’s sales results were ―. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
